Q1 2026 Management View “Our company has started 2026 on a strong note by achieving record revenue of $12.1 million for the quarter,” and this was “driven primarily by organic devices growth of 25%,” ...

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management ...

Earnings call ClearPoint Neuro delivered record Q1 2026 revenue of $12.1M, up 43% YoY (16% organic), driven by device growth and the IRRAflow acquisition. Gross margin expanded to 64% (+4pp YoY), and ...

STOCKHOLM, April 24, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical technology company focused on developing and commercializing innovative solutions for ...

STOCKHOLM, Sweden, Dec. 19, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE ...

STOCKHOLM, Dec. 9, 2019 /PRNewswire/ -- IRRAS AB (NASDAQ Stockholm: IRRAS), a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today ...